TF and Parkinson disease: We chose to use a slightly higher dose of apo-Tf in the MPP+ paradigm (20 μM) compared with that of the non-intoxicated cells presented in Figure 2a (1–10 μM) because Tf-mediated iron efflux is impaired in PD, and in PD models.8,10,11